Aspirin DL-lysine
Based on 1 publication(s) in Google Scholar
Aspirin DL-lysine (ASA DL-lysine) is a lysine-containing aspirin derivative. Aspirin DL-lysine inhibits cyclooxygenase (COX) in platelets, blocks the synthesis of thromboxane A2 (TXA2), and thus inhibits platelet aggregation and activation. Aspirin DL-lysine can be used to study thrombin generation in patients with unstable angina pectoris.
For research use only. We do not sell to patients.
- CAS No.: 62952-06-1
- Formula: C15H22N2O6
- Molecular Weight:326.34
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Aspirin DL-lysine
More
Biological Activity
Chemical Information
-
CAS No. 62952-06-1
-
Molecular Weight 326.34
-
Formula C15H22N2O6
-
SMILES
O=C(C1=C(OC(C)=O)C=CC=C1)O.O=C(C(CCCCN)N)O
-
Synonyms
Acetylsalicylic acid DL-lysine; ASA DL-lysine
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Pharmaceuticals (Basel)
Photothermal Therapy Combined with Chemotherapy and Anti-Inflammation Therapy Weakens the Immunosuppression of Cervical Cancer. [Abstract]2025 Nov 1;18(11):1657. PMID: 41304902
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)